Joseph McCracken, Director at Nexvet Biopharma, holds 210.84K shares in Savara (Ticker: SVRA), holds 15.72K shares in Lumos Pharma (Ticker: LUMO), holds 6.20K shares in Nexvet Biopharma (Ticker: NVET). Most recently, Joseph McCracken Bought ― shares of Savara on Nov 20, 2024 for an estimated value of 59.00K.
What is the percentage of profitable transactions made by Joseph McCracken?
The percentage of profitable transactions made by Joseph McCracken is 50%.
What is the average return per transaction made by Joseph McCracken?
The average return per transaction made by Joseph McCracken is 1.50%.
What stocks does Joseph McCracken hold?
Joseph McCracken holds: NVET, SVRA, KIN, LUMO stocks.
What was Joseph McCracken’s latest transaction?
Joseph McCracken latest transaction was an Informative Buy of $59.00K.
What was Joseph McCracken's most profitable transaction?
Joseph McCracken’s most profitable transaction was an Informative Buy of SVRA stock on June 9, 2017. The return on the trade was 85.20%.
What is Joseph McCracken's role in Nexvet Biopharma?
Joseph McCracken's role in Nexvet Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.